Global Psychedelic Drugs Market Size & Share to 2027
Global Psychedelic Drugs Market Size, Trends & Growth Opportunity, By Drug Type (Lysergic Acid Diethylamide (LSD), 3,4-MethylEnedioxyMethamphetamine (Ecstasy), Phencyclidine, Gamma Hydroxybutyric Acid (GHB), Ketamine, Ayahuasca, Salvia, Psilocybin, and Others) By Route of Administration (Oral, Injectable, and Inhalation), By Distribution Channel, By Region and Forecast till 2027
Global Psychedelic Drugs Market
Psychedelic is called as psychedelics, which is class of hallucinogenic drugs including both classic hallucinogens and dissociative drugs which are used recreationally, to enhance the sensory perception, elevate the mood swings, energy level promoting spiritual experiences, and thought process. These drugs have been used experimentally for psychological treatment.
Market Drivers
Increase in prevalence of depression across the globe is the key driving factor which is expected to boost the global psychedelic drugs market growth. Furthermore, change in lifestyle and requirement for enhanced and better life quality will positively contribute the market growth. Also, increase in research and development activities is expected to propel the market growth during this analysis period. Moreover, increase in dependency on psychedelic drugs for treatment of depression is expected to propel the global psychedelic drugs market growth during this forecast period.
Market Restraints
However, stringent rules and regulations imposed by government to commercialize psychedelic drugs is the major challenging factor which is expected to hinder the global psychedelic drugs market growth. Also, poor efficiency and safety profile of existing intervention will affect the market growth over the forecast period.
Market Segmentation
Global Psychedelic Drugs Market is segmented into drug type such as Lysergic Acid Diethylamide (LSD), 3,4-MethylEnedioxyMethamphetamine (Ecstasy), Phencyclidine, Gamma Hydroxybutyric Acid (GHB), Ketamine, Ayahuasca, Salvia, Psilocybin, and Others, by route of administration such as Oral, Injectable, and Inhalation, by distribution channel such as Direct Retailers, Online Pharmacies, and Others. Further, market is segmented into End –Users such as Hospitals, Homecare, Specialty Clinics, and others.
Also, Global Psychedelic Drugs Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
Market Key Players
Various key players are discussed in this report such as AstraZeneca,, COMPASS,, Klarisana, F. Hoffmann-La Roche Ltd, Takeda Pharmaceutical Company Limited,, Dr. Reddy’s Laboratories Ltd,, Pfizer Inc,, Merck & Co., Inc, ,and Lundbeck A/S
Market Taxonomy
By Drug Type
- Lysergic Acid Diethylamide (LSD)
- 3,4-MethylEnedioxyMethamphetamine (Ecstasy)
- Phencyclidine
- Gamma Hydroxybutyric Acid (GHB)
- Ketamine
- Ayahuasca
- Salvia
- Psilocybin
- Others
- Oral
- Injectable
- Inhalation
- Direct Retailers
- Online Pharmacies
- Others
- Hospitals
- Homecare
- Specialty Clinics
- Others
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
- What are the Key Opportunities in Global Psychedelic Drugs Market?
- What will be the growth rate from 2019 to 2027?
- Which segment/region will have highest growth?
- What are the factors that will impact/drive the Market?
- What is the competitive Landscape in the Industry?
- What is the role of key players in the value chain?
- What are the strategies adopted by key players?
- 1 Introduction
- 1.1 Objective of the Study
- 1.2 Market Definition
- 1.3 Market Scope
- 2 Research Methodology
- 2.1 Data Mining
- 2.2 Validation
- 2.3 Primary Interviews
- 2.4 List of Data Sources
- 3 Executive Summary
- 4 Global Psychedelic Drugs Market Outlook
- 4.1 Overview
- 4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
- 4.3 Porters Five Force Model
- 4.4 Value Chain Analysis
- 5 Global Psychedelic Drugs Market, By Drug Type
- 5.1 Y-o-Y Growth Comparison, By Drug Type
- 5.2 Global Psychedelic Drugs Market Share Analysis, By Drug Type
- 5.3 Global Psychedelic Drugs Market Size and Forecast, By Drug Type
- 5.3.1 Lysergic Acid Diethylamide (LSD)
- 5.3.2 3,4-MethylEnedioxyMethamphetamine (Ecstasy)
- 5.3.3 Phencyclidine
- 5.3.4 Gamma Hydroxybutyric Acid (GHB),
- 5.3.5 Ketamine
- 5.3.6 Ayahuasca
- 5.3.7 Salvia
- 5.3.8 Psilocybin
- 5.3.9 Others
- 6 Global Psychedelic Drugs Market, By Route of Administration
- 6.1 Y-o-Y Growth Comparison, By Route of Administration
- 6.2 Global Psychedelic Drugs Market Share Analysis, By Route of Administration
- 6.3 Global Psychedelic Drugs Market Size and Forecast, By Route of Administration
- 6.3.1 Oral
- 6.3.2 Injectable
- 6.3.3 Inhalation
- 7 Global Psychedelic Drugs Market, By Distribution Channel
- 7.1 Y-o-Y Growth Comparison, By Distribution Channel
- 7.2 Global Psychedelic Drugs Market Share Analysis, By Distribution Channel
- 7.3 Global Psychedelic Drugs Market Size and Forecast, By Distribution Channel
- 7.3.1 Direct Retailers
- 7.3.2 Online Pharmacies
- 7.3.3 Others
- 8 Global Psychedelic Drugs Market, By End User
- 8.1 Y-o-Y Growth Comparison, By End User
- 8.2 Global Psychedelic Drugs Market Share Analysis, By End User
- 8.3 Global Psychedelic Drugs Market Size and Forecast, By End User
- 8.3.1 Hospitals
- 8.3.2 Homecare
- 8.3.3 Speciality Clinics
- 8.3.4 Others
- 9 Global Psychedelic Drugs Market, By Region
- 9.1 Global Psychedelic Drugs Market Share Analysis, By Region
- 9.2 Global Psychedelic Drugs Market Share Analysis, By Region
- 9.3 Global Psychedelic Drugs Market Size and Forecast, By Region
- 10 North America Psychedelic Drugs Analysis and Forecast (2020 – 2027)
- 10.1 Introduction
- 10.2 North America Psychedelic Drugs Product Market Share Analysis, By Drug Type
- 10.3 North America Psychedelic Drugs Product Market Size and Forecast, By Route of Administration
- 10.4 North America Psychedelic Drugs Product Market Size and Forecast, By Distribution Channel
- 10.5 North America Psychedelic Drugs Product Market Size and Forecast, By End User
- 10.6 North America Psychedelic Drugs Product Market Size and Forecast, By Country
- 10.6.1 U.S.
- 10.6.2 Canada
- 10.6.3 Mexico
- 11 Europe Psychedelic Drugs Market Analysis and Forecast (2020 – 2027)
- 11.1 Introduction
- 11.2 Europe Psychedelic Drugs Product Market Share Analysis, By Drug Type
- 11.3 Europe Psychedelic Drugs Product Market Size and Forecast, By Route of Administration
- 11.4 Europe Psychedelic Drugs Product Market Size and Forecast, By Distribution Channel
- 11.5 Europe Psychedelic Drugs Product Market Size and Forecast, By End User
- 11.6 Europe Psychedelic Drugs Product Market Size and Forecast, By Country
- 11.6.1 Germany
- 11.6.2 France
- 11.6.3 UK
- 11.6.4 Rest of Europe
- 12 Asia Pacific Psychedelic Drugs Market Analysis and Forecast (2020 – 2027)
- 12.1 Introduction
- 12.2 Asia Pacific Psychedelic Drugs Product Market Share Analysis, By Drug Type
- 12.3 Asia Pacific Psychedelic Drugs Product Market Size and Forecast, By Route of Administration
- 12.4 Asia Pacific Psychedelic Drugs Product Market Size and Forecast, By Distribution Channel
- 12.5 Asia Pacific Psychedelic Drugs Product Market Size and Forecast, By End User
- 12.6 Asia Pacific Psychedelic Drugs Product Market Size and Forecast, By Country
- 12.6.1 China
- 12.6.2 Japan
- 12.6.3 India
- 12.6.4. Rest of Asia Pacific
- 13 Latin America Psychedelic Drugs Market Analysis and Forecast (2020 – 2027)
- 13.1 Introduction
- 13.2 Latin America Psychedelic Drugs Product Market Share Analysis, By Drug Type
- 13.3 Latin America Psychedelic Drugs Product Market Size and Forecast, By Route of Administration
- 13.4 Latin America Psychedelic Drugs Product Market Size and Forecast, By Distribution Channel
- 13.5 Latin America Psychedelic Drugs Product Market Size and Forecast, By End User
- 13.6 Latin America Psychedelic Drugs Product Market Size and Forecast, By Country
- 14 Middle East Psychedelic Drugs Market Analysis and Forecast (2020 – 2027)
- 14.1 Introduction
- 14.2 Middle East Psychedelic Drugs Product Market Share Analysis, By Drug Type
- 14.3 Middle East Psychedelic Drugs Product Market Size and Forecast, By Route of Administration
- 14.4 Middle East Psychedelic Drugs Product Market Size and Forecast, By Distribution Channel
- 14.5 Middle East Psychedelic Drugs Product Market Size and Forecast, By End User
- 14.6 Middle East Psychedelic Drugs Product Market Size and Forecast, By Country
- 15 Competitive Analysis
- 15.1 Competition Dashboard
- 15.2 Market share Analysis of Top Vendors
- 15.3 Key Development Strategies
- 16 Company Profiles
- 16.1 AstraZeneca
- 16.1.1 Overview
- 16.1.2 Offerings
- 16.1.3 Key Financials
- 16.1.4 Business Segment & Geographic Overview
- 16.1.5 Key Market Developments
- 16.1.6 Key Strategies
- 16.2 COMPASS
- 16.2.1 Overview
- 16.2.2 Offerings
- 16.2.3 Key Financials
- 16.2.4 Business Segment & Geographic Overview
- 16.2.5 Key Market Developments
- 16.2.6 Key Strategies
- 16.3 Klarisana
- 16.3.1 Overview
- 16.3.2 Offerings
- 16.3.3 Key Financials
- 16.3.4 Business Segment & Geographic Overview
- 16.3.5 Key Market Developments
- 16.3.6 Key Strategies
- 16.4 F. Hoffmann-La Roche Ltd
- 16.4.1 Overview
- 16.4.2 Offerings
- 16.4.3 Key Financials
- 16.4.4 Business Segment & Geographic Overview
- 16.4.5 Key Market Developments
- 16.4.6 Key Strategies
- 16.5 Takeda Pharmaceutical Company Limited
- 16.5.1 Overview
- 16.5.2 Offerings
- 16.5.3 Key Financials
- 16.5.4 Business Segment & Geographic Overview
- 16.5.5 Key Market Developments
- 16.5.6 Key Strategies
- 16.6 Dr. Reddy’s Laboratories Ltd
- 16.6.1 Overview
- 16.6.2 Offerings
- 16.6.3 Key Financials
- 16.6.4 Business Segment & Geographic Overview
- 16.6.5 Key Market Developments
- 16.6.6 Key Strategies
- 16.7 Pfizer Inc
- 16.7.1 Overview
- 16.7.2 Offerings
- 16.7.3 Key Financials
- 16.7.4 Business Segment & Geographic Overview
- 16.7.5 Key Market Developments
- 16.7.6 Key Strategies
- 16.8 Merck & Co., Inc
- 16.8.1 Overview
- 16.8.2 Offerings
- 16.8.3 Key Financials
- 16.8.4 Business Segment & Geographic Overview
- 16.8.5 Key Market Developments
- 16.8.6 Key Strategies
- 16.9 Lundbeck A/S
- 16.9.1 Overview
- 16.9.2 Offerings
- 16.9.3 Key Financials
- 16.9.4 Business Segment & Geographic Overview
- 16.9.5 Key Market Developments
- 16.9.6 Key Strategies
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook